Radiation Oncology

Editor-in-Chief

Claus Belka, Munich

Editorial Board | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Short report

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Manapov F, Sepe S, Niyazi M, Belka C, Friedel G and Budach W Radiation Oncology 2013, 8:122 (17 May 2013)
Research

Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy

Lin H, Lin HX, Ge N, Wang HZ, Sun R and Hu WH Radiation Oncology 2013, 8:121 (15 May 2013)
Research

Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams

Zhuang M, Zhang T, Chen Z, Lin Z, Li D, Peng X, Qiu Q and Wu R Radiation Oncology 2013, 8:120 (14 May 2013)
Research

Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy

Wu SG, Chen Y, Sun JY, Li FY, Lin Q, Lin HX and He ZY Radiation Oncology 2013, 8:119 (14 May 2013)
Research

Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years

Katz AJ, Santoro M, Diblasio F and Ashley R Radiation Oncology 2013, 8:118 (13 May 2013)
Research

Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma

Xie X, Wang H, Jin H, Ouyang S, Zhou J, Hu J, Xi X, Luo J et al. Radiation Oncology 2013, 8:117 (11 May 2013)
Research

Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer

Xu Y, Liu J, Du X, Sun X, Zheng Y, Chen J, Li B, Liu W et al. Radiation Oncology 2013, 8:116 (8 May 2013)
View more articles

RSS

Comments

Typo in Table 2

Comment on: Van Parijs et al. Radiation Oncology 2013, 7:80
trade-off between PTV coverage and OAR doses

Comment on: Wiezorek et al. Radiation Oncology 2011, 6:20
Skin thickness data

Comment on: Wong et al. Radiation Oncology 2011, 6:9

Aims & scope

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.

Latest review

Continuous controversy about radiation oncologists’ choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

Nieder C, Pawinski A and Dalhaug A

Radiation Oncology 2013, 8:85

Editor's profile

Professor Claus Belka

Professor Belka is Head of the Department of Radiation Oncology at the University Hospital, Munich and a Member of the European Society for Therapeutic Radiology and Oncology Board of Directors. His current interests include radiobiology, especially apoptosis, and high precision radiotherapy (IGRT, IMRT).

Advertisement

Submit a manuscript Register Contact us Follow
BioMed Central Support

Advertisement

Indexed by

CAS
Embase
MEDLINE
PubMed
PubMed Central
Science Citation Index Expanded
Scopus

View all

ISSN: 1748-717X

Editor-in-Chief

Articles

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy

Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy

Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams

Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy

Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years

Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma

Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer